JU Gutterman
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 15
- Chronic Myeloid Leukemia Treatments 10
- Acute Myeloid Leukemia Research 6
- Oncology 8
- Cytokine Signaling Pathways and Interactions 5
- Co-authors
- Moshe Talpaz (9 shared papers)KB McCredie (4 shared papers)Saroj Vadhan‐Raj (6 shared papers)A LeMaistre (5 shared papers)HE Broxmeyer (4 shared papers)Razelle Kurzrock (6 shared papers)S Buescher (3 shared papers)Loretta M. Itri (1 shared paper)
- Partner nations
- United States
In The Last Decade
JU Gutterman
23 papers receiving 871 citations
Peers
Comparison fields: 5 of 59
- Hematology 606
- Genetics 345
- Immunology 225
- Oncology 253
- Rheumatology 127
Countries citing papers authored by JU Gutterman
This map shows the geographic impact of JU Gutterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JU Gutterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JU Gutterman more than expected).
Fields of papers citing papers by JU Gutterman
This network shows the impact of papers produced by JU Gutterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JU Gutterman. The network helps show where JU Gutterman may publish in the future.
Co-authors
The 25 scholars most cited alongside JU Gutterman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 271 | |
| 2 | 1988 | 124 | |
| 3 | 1986 | 102 | |
| 4 | 1979 | 87 | |
| 5 | 1991 | 85 | |
| 6 | 1990 | 70 | |
| 7 | 1989 | 54 | |
| 8 | 1987 | 40 | |
| 9 | 1987 | 29 | |
| 10 | 1990 | 24 | |
| 11 | 1983 | 12 | |
| 12 | 1974 | 12 | |
| 13 | 1990 | 9 | |
| 14 | 1992 | 6 | |
| 15 | 1991 | 5 | |
| 16 | 1987 | 4 | |
| 17 | 1979 | 3 | |
| 18 | 1986 | 2 | |
| 19 | 1989 | 2 | |
| 20 | 1990 | 2 |
About JU Gutterman
JU Gutterman is a scholar working on Hematology, Oncology, Immunology, Genetics and Rheumatology, having authored 23 papers that have together received 948 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (10 papers), Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), Eosinophilic Disorders and Syndromes (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Hematological disorders and diagnostics (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Hematology (606 citations), Genetics (345 citations), Immunology (225 citations), Oncology (253 citations) and Rheumatology (127 citations). JU Gutterman has collaborated with scholars based in United States. Frequent co-authors include Moshe Talpaz, KB McCredie, Saroj Vadhan‐Raj, A LeMaistre, HE Broxmeyer, Razelle Kurzrock, S Buescher, Loretta M. Itri, B Barlogie and Ernest C. Borden. Their work appears in journals such as Blood, Pathology and Experimental Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.